Idiopathic Granulomatous Mastitis: A Retrospective Cohort Study of Treatment Modalities in 83 Patients From Southern Thailand

Authors

  • Puttiporn Puttawibul Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  • Siripen Kanchanasuwan Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  • Suphawat Laohawiriyakamol Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.

DOI:

https://doi.org/10.31584/jhsmr.20241079

Keywords:

breast disease, granulomatous, idiopathic granulomatous mastitis, IGM, mastitis

Abstract

Objective: Idiopathic granulomatous mastitis (IGM) is a rare condition that mimics breast cancer. Current treatment strategies include both surgical and medical therapy. This study aimed to report and describe the clinical signs, radiological findings, management, clinical course, and outcomes after treatment of IGM, from a major tertiary care institute in southern Thailand.
Material and Methods: The medical records of 83 patients with IGM treated at our institute between January 2001 and April 2022 were retrospectively studied. Patient characteristics, clinical presentations, radiological findings, microbiological workups, tissue pathologies, treatment modalities, outcomes and follow-up data were reviewed and analyzed. The success rate, recurrence rate, and time to heal were compared between the different treatment modalities.
Results: Overall, 83 patients were diagnosed with IGM. Due to insufficient follow-up periods, data from only 50 patients were used for the analysis. Initially, 34,3,8, and 5 were treated surgically, with steroids, anti-tuberculosis (TB) drugs, or other treatments, respectively; 32 (64%) achieved disease resolution. The median time to heal was 472 days, while the median time to heal after surgery, steroid therapy, anti-TB therapy, and others was 614.5, 333, 208.5, and 406 days, respectively. Surgery resulted in the longest time to heal; however, the difference was not statistically significant (p-value=0.23). Eighteen (36%) patients experienced recurrence.
Conclusion: There was no significant difference among the treatment modalities in terms of time to heal and recurrence. Surgery resulted in the longest healing time, the highest incidence of complications, and a recurrence rate of approximately 50%. Surgical treatment should be reserved for aggressive diseases.

References

Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol 1972;58:642-6.

Khalaf A, El-Shemy GG. The myth of idiopathic granulomatous mastitis. Int Medical J 2020;1:116-23.

Chirappapha P, Thaweepworadej P, Supsamutchai C, Biadul N, Lertsithichai P. Idiopathic granulomatous mastitis: a retrospective cohort study between 44 patients with different treatment modalities. Ann Med Surg (Lond) 2018;36:162-7.

Gautier N, Lalonde L, Tran-Thanh D, Khoury ME, David J, Labelle M, et al. Chronic granulomatous mastitis: Imaging, pathology and management. Eur J Radiol 2013;82:e165-e75.

Yilmaz E, Lebe B, Usal C, Balci P. Mammographic and sonographic findings in the diagnosis of idiopathic granulomatous mastitis. Eur Radiol 2001;11:2236-40.

Li SB, Xiong Y, Han XR, Liu ZY, Lv XL, Ning P. Pregnancy associated granulomatous mastitis: clinical characteristics, management, and outcome. Breastfeed Med 2021;16:759-64.

Yuan QQ, Xiao SX, Farouk O, Du YT, Sheybani F, Tan QT, et al. Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition). Mil Med Res 2022;9:20.

Katz U, Molad Y, Ablin J, Ben-David D, Paran D, Gutman M, et al. Chronic idiopathic granulomatous mastitis. Ann N Y Acad Sci 2007;1108:603-8.

Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World J Clin Cases 2014;2:852-8.

Gunduz Y, Altintoprak F, Tatli Ayhan L, Kivilcim T, Celebi F. Effect of topical steroid treatment on idiopathic granulomatous mastitis: clinical and radiologic evaluation. Breast J 2014;20:586-91.

Imoto S, Kitaya T, Kodama T, Hasebe T, Mukai K. Idiopathic granulomatous mastitis: case report and review of the literature Jpn J Clin Oncol 1997;27:274-7.

Bani-Hani KE, Yaghan RJ, Matalka II, Shatnawi NJ. Idiopathic granulomatous mastitis: time to avoid unnecessary mastectomies. Breast J 2004;10:318-22.

Toktas O, Konca C, Trabulus DC, Soyder A, Koksal H, Karanlik H, et al. A novel first-line treatment alternative for noncomplicated idiopathic granulomatous mastitis: combined intralesional steroid injection with topical steroid administration. Breast Care (Basel) 2021;16:181-7.

Williams MS, McClintock AH, Bourassa L, Laya MB. Treatment of granulomatous mastitis: is there a role for antibiotics? Eur J Breast Health 2021;17:239-46.

Sheybani F, Sarvghad M, Naderi H, Gharib M. Treatment for and clinical characteristics of granulomatous mastitis. Obstet Gynecol 2015;125:801-7.

DeHertogh DA, Rossof AH, Harris AA, Economou SG. Prednisone management of granulomatous mastitis. N Engl J Med 1980;303:799-800.

Lai ECH, Chan WC, Ma TKF, Tang APY, Poon CSP, Leong HT. The role of conservative treatment in idiopathic granulomatous mastitis. Breast J 2005;11:454-6.

Mahmodlou R, Dadkhah N, Abbasi F, Nasiri J, Valizadeh R. Idiopathic granulomatous mastitis: dilemmas in diagnosis and treatment. Electron Physician 2017;9:5375-9.

Kornfeld HW, Mitchell KB. Management of idiopathic granulomatous mastitis in lactation: case report and review of the literature. Int Breastfeed J 2021;16:1-6.

Çetin K, Sıkar HE, Göret NE, Rona G, Barışık NÖ, Küçük HF, et al. Comparison of topical, systemic, and combined therapy with steroids on idiopathic granulomatous mastitis: a prospective randomized study. World J Surg 2019;43:2865-73.

Dobinson HC, Anderson TP, Chambers ST, Doogue MP, Seaward L, Werno AM. Antimicrobial treatment options for granulomatous mastitis caused by corynebacterium species. J Clin Microbiol 2015;53:2895-9.

Yalcin Kehribar D, Izci Duran T, Kamali Polat A, Ozgen M. AB1053 Effectiveness of methotrexate in idiopathic granulomatous mastitis treatment. Ann Rheum Dis 2020;79(Suppl 1):1816.

Salehi M, Salehi M, Kalbasi N, Hakamifard A, Salehi H, Salehi MM, et al. Corticosteroid and Azithromycin in idiopathic granulomatous mastitis. Adv Biomed Res 2017;6:1-4.

Al-Khaffaf B, Knox F, Bundred NJ. Idiopathic granulomatous mastitis: a 25-year experience. J Am Coll Surg 2008;206:269-73.

Uysal E, Soran A, Sezgin E, Granulomatous mastitis study G. Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study? ANZ J Surg 2018;88:635-9.

Farrokh D, Alamdaran A, Feyzi Laeen A, Fallah Rastegar Y, Abbasi B. Tuberculous mastitis: a review of 32 cases. Int J Infect Dis 2019;87:135-42.

Going JJ, Anderson TJ, Wilkinson S, Chetty U. Granulomatous lobular mastitis. J Clin Pathol 1987;40:535-40.

Deng Y, Xiong Y, Ning P, Wang X, Han X-R, Tu G-F, et al. A case management model for patients with granulomatous mastitis: a prospective study. BMC Women’s Health 2022;143:1-12.

Yau FM, Macadam SA, Kuusk U, Nimmo M, Van Laeken N. The surgical management of granulomatous mastitis. Ann Plast Surg 2010;64:9-16.

Hladik M, Schoeller T, Ensat F, Wechselberger G. Idiopathic granulomatous mastitis: successful treatment by mastectomy and immediate breast reconstruction. J Plast Reconstr Aesthet Surg 2011;64:1604-7.

Taghizadeh R, Shelley OP, Chew BK, WeilerMithoff EM. Idiopathic granulomatous mastitis: surgery, treatment, and reconstruction. Breast J 2007;13:509-13.

Downloads

Published

2024-12-19

How to Cite

1.
Puttawibul P, Kanchanasuwan S, Laohawiriyakamol S. Idiopathic Granulomatous Mastitis: A Retrospective Cohort Study of Treatment Modalities in 83 Patients From Southern Thailand. J Health Sci Med Res [Internet]. 2024 Dec. 19 [cited 2024 Dec. 22];43(1):e20241079. Available from: https://he01.tci-thaijo.org/index.php/jhsmr/article/view/275919

Issue

Section

Original Article